Rabat: Speaking during question time at the House of Representatives, Health Minister Tahraoui announced that Morocco has reached a consensus on a new drug price reform decree. The reform initiative was developed through a participatory process involving over 30 meetings with key stakeholders, including industrial federations, pharmacists’ associations, and insurance representatives.
According to Agence Marocaine De Presse, the new model introduces principles aimed at reducing the time required for price revision, implementing the reform gradually to maintain stability, ensuring the availability of low-cost drugs, and supporting local production. The draft decree is in its final stage and will soon be presented to the Government Council for adoption. Tahraoui emphasized that the reform approach is comprehensive, addressing legal, technical, and socio-economic aspects.
The minister highlighted that the government considers drug pricing reform a sovereign and responsible choice, with a socio-economic focus on
strengthening citizens’ purchasing power, ensuring equitable access to medicines, and fostering domestic investment in the pharmaceutical sector. Plans include a unified national logistics platform to supply public health facilities with medicines and medical devices, addressing issues of stockouts and expired drugs to reduce annual losses, with gradual implementation over 18 months.
In the area of vaccine sovereignty, Tahraoui announced procurement contracts with the Benslimane-based firm Marbio for vaccines including pneumococcal, meningococcal, and hexavalent. Allocations exceeding one billion dirhams aim to secure 5.4 million doses for 2025 and 2026. A scientific committee has been established to update the national vaccination schedule and approve the first locally produced vaccines, with initial deliveries expected by the end of 2025.
Tahraoui concluded by framing the reform as a foundation for a new national model in medicines and vaccines, centered on sovereignty, transparency, local production, and
equitable distribution, with citizens’ health and dignity as primary considerations.